Production (Stage)
Exagen Inc.
XGN
$6.60
$0.579.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.50% | 9.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.50% | 9.18% | |||
| Cost of Revenue | 23.12% | -6.30% | |||
| Gross Profit | 7.62% | 21.43% | |||
| SG&A Expenses | 9.80% | 0.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.71% | -0.77% | |||
| Operating Income | 0.53% | 27.45% | |||
| Income Before Tax | -0.08% | 25.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.24% | 25.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.24% | 25.20% | |||
| EBIT | 0.53% | 27.45% | |||
| EBITDA | 1.45% | 30.02% | |||
| EPS Basic | 0.93% | 25.89% | |||
| Normalized Basic EPS | 0.63% | 26.09% | |||
| EPS Diluted | 0.93% | 25.89% | |||
| Normalized Diluted EPS | 0.63% | 26.09% | |||
| Average Basic Shares Outstanding | 0.70% | 0.95% | |||
| Average Diluted Shares Outstanding | 0.70% | 0.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||